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Aims: The relationship between operator volume and outcomes for percutaneous coronary intervention has been studied in the past, but recent analyses of national data covering the modern radial, ACS-dominant era are limited. Changing in case-mix, practice and service provision mean that previously described volume-outcome relationships may no longer be relevant, and a reassessment in contemporary practice is needed. We aim to assess whether operator volume is associated with independently reported 30-day mortality in a contemporary PCI cohort.
Methods and Results: This observational cohort study analysed procedures recorded in the British Cardiovascular Intervention Society PCI database from 2013 to 2014 in England and Wales. Mixed effects multiple logistic regression modeling was used to account for operator and centre level effects and to adjust for potential confounders. Volume is defined as the total number of procedures the operator was responsible for in the previous 12 months.
133,970 procedures were analysed. Median volume across all procedures was 178 per year (IQR 128-239). The 30-day mortality rate was 2.6%. After adjustment for case-mix, the association between volume and mortality was negligible (Odds-ratio per 100 procedures = 0.99, 95% CI = 0.93 to 1.05, p=0.725). Sensitivity analyses showed similar results amongst high-risk PCI subsets and in-hospital outcomes.






	The impact of operator volume on outcomes following interventional medical procedures is of great interest across many specialties1,2, including percutaneous coronary intervention (PCI). The current body of evidence describing this relationship is discrepant, with some studies reporting that higher operator volume is related to improved outcomes via reductions in in-hospital mortality or other adverse events3–7, and others reporting no such association8–16. While the exact nature and extent of the volume-outcome relationship in PCI is unclear, there remains an intuitive concern that interventional cardiologists who do more cases are likely to be better operators. Therefore, there is a consensus that operators should exceed a minimum number of procedures per year to maintain a high standard of manual skills and sound clinical judgment in order to achieve competency.
	Current national and international guidelines offer recommendations on minimum operator PCI volume17–19 that are summarised in Table 1. These guidelines rely on data from no later than 201016, and reflect the typical activity levels, patient characteristics and operator practices at that time. In many countries, the case mix for PCI has changed from predominantly elective to an increased proportion of acute coronary syndromes (ACS) and this has been accompanied by a growth in PCI services to increase patient access. In addition, much of the interventional equipment, technologies and pharmacology have evolved and therefore, existing literature regarding the association between PCI volume and outcome may no longer apply to contemporary practice. Two recent studies have examined patient outcomes in relation to volume in contemporary data7,15, though data from a European perspective with a different healthcare delivery model are lacking. 
	There are also several methodological limitations in many volume-outcome studies20. The existing literature almost exclusively relies on a categorised definition of annualised volume that differs greatly from study to study, for instance the high/low volume threshold has varied from as low as 11 procedures per year14 or as high as 10011 and synthesising such results is challenging. The use of fixed calendar year volume is also problematic as, for instance, outcomes of procedures performed in January are modelled based on procedural volume up to 11 months later in December. Future volume should not be used to predict previous outcomes.
	In this recent (2013-2014) British cohort study we report crude and risk-adjusted short-term PCI mortality outcomes in relation to operator volume. It is the first time that this relationship has been examined from a national perspective in Europe, and the first to use a pragmatic, non-categorised definition of operator volume. The suitability of existing international volume guidelines is assessed. 
Methods
Study design
	This retrospective, observational cohort study analysed procedures recorded in the BCIS PCI database in the two-year period from 1 January 2013 to 31 December 2014 to assess whether operator volume is associated with independently reported 30-day mortality. Mixed effects multiple logistic regression modeling was used to account for operator and centre level effects and to adjust for potential confounders. 
The BCIS Database
	The BCIS collects data on all PCI procedures in the UK. Data input on every case is mandated by UK Good Practice guidelines and is a specified responsibility of senior operators as part of their revalidation by the General Medical Council (GMC). The data collection is coordinated by the National Institute of Cardiovascular Outcomes Research (NICOR) via a centralised electronic database21. The BCIS-NICOR registry comprises 113 variables, including clinical variables, procedural parameters and patient outcomes. Mortality tracking is undertaken by NHS Digital linkage with each patients’ NHS number that provides a unique identifier for any person registered with the NHS in England and Wales. Because it is a legal requirement for all deaths in the UK to be registered, these life status data are robust.
Volume definition
	The GMC registration number of the ‘consultant responsible for the procedure’ was used to identify operators.  This is a unique identifier of the consultant PCI operator and has been part of the BCIS registry since 2012. Our annualised volume metric, updated each month, is defined as the total number of procedures the consultant was responsible for in the previous 12 months across all NHS centres. For example, consultant volume in February 2013 is measured from February 2012 to January 2013.
Cohort selection
	All PCI procedures undertaken in the NHS in England and Wales recorded in the BCIS registry from 1 January 2013 to 31 December 2014 were considered in this analysis. Mortality tracking was not available in Northern Ireland or Scotland hence procedures performed in these countries were excluded, though any activity in these nations contributed to each consultant’s volume should an operator have crossed geographic boundaries during the study period. Similarly, activity in 2012 contributed to each consultant’s volume where necessary. Procedures were excluded where mortality, indication, sex or age were missing, and where patients were recorded as younger than 18 or over 100 years old. Additional exclusions were made where volume could not be reliably determined: three out of 87 centres had missing data for over 10% of the ‘consultant responsible for the procedure’ field and all procedures from these centres were removed from the analysis (n=6,145 procedures, 4.1%). Missing consultant identifier rates for all remaining centres was less than 3.3% and these procedures were removed (n=2,891, 1.9%). Procedures where the consultant was in their first year in the registry were removed (7,053, 4.7%) as volume could not be calculated in these cases. For further details refer to the supplementary materials. 
Statistical analysis
	Baseline patient and procedural characteristics were reported, stratified by volume quartiles (Q1 0-128; Q2 129-178; Q3 179-239; Q4 240-714), such that each strata contained an equal number of procedures (approximate due to ties), with the possibility that the same operator was present in multiple strata if her case volume moved across strata boundaries during the study period. These strata boundaries were reused to show baseline characteristic for elective and ACS procedures separately. Histograms and quantiles were used to describe the distribution of average volume across operators.
	To investigate the association between volume and 30-day mortality in the presence of confounding and clustering effects, we used multivariable, mixed effects logistic regression modeling, using multiple imputation to account for missing values.
	First, missing values were imputed using fully conditional specification multiple imputation with 20 imputed datasets created. Continuous variables were imputed using predictive mean matching and categorical variables using multinomial logistic regression. Imputation was not necessary for consultant and centre identifiers, volume metrics and mortality, as these were complete by design. A complete list of variables used in the imputation model is provided in the supplementary materials. Information on completeness for each variable is provided in Supplementary Table A1. Effect estimates across imputed datasets were pooled using Rubin’s rules.22 
	The multivariable mixed effects model adjusted for age, sex, ethnicity, PCI indication, cardiogenic shock, intra-aortic balloon-pump support, cardio-pulmonary support, inotropic support, ventilation, left ventricular ejection fraction (LVEF), MI history, CABG history, high cholesterol, hypertension, diabetes status, renal status, smoking status, and centre volume (defined as the number of procedures performed by a centre in the previous 12 months and updated monthly). Covariates were included to adjust the models, not to provide information on their associations with outcomes, which has been more robustly achieved with patient-level analyses in other work.23–25 Operator- and centre-level random effects were included, and these were not nested as operators often worked across multiple centres. The Wald-like test due to Li, Raghunathan and Rubin26 was used to provide reference p-values for model odds-ratios (OR) and associated confidence intervals (CI). The intra-class correlation coefficient (ICC) due to Wu, Crespi and Wong27 was used to assess the variation in outcomes explained by operator- and centre-level clustering before and after the inclusion of fixed-effects. These values are reported in supplementary materials.
	Smoothed curves which showed the observed (unadjusted) mortality and model-adjusted mortality against volume to explore possible non-linear relationships.
	The analysis was repeated in the subset of patients undergoing PCI for ACS, with ACS volume derived in an analogous way to overall volume. Both volume metrics were considered simultaneously in the same regression model, so that the model comparison test assesses the improvement in the goodness-of-fit of the model when adding both volume and ACS volume as linear effects. Subsetting was carried out after multiple imputation so that the same imputed data were used throughout. The analysis was also repeated in the subset of patients undergoing primary PCI in exactly the manner described for the ACS sub-analysis, using primary PCI volume.
	Due to the size of the dataset we focus on effect estimates and their interpretations and not on p-values28. Arbitrary significance thresholds are not used. Additional methodological details are provided in supplementary materials.
Sensitivity analyses
	We varied our methods in four different ways to assess the consistency of our results under alternative study designs. 
The first of these was to change the outcome from 30-day mortality to centre-reported in-hospital mortality (was the patient discharged alive or not) and also in-hospital MACE (Major Adverse Cardiovascular Events, defined here as myocardial infarction, emergency re-intervention via CABG or PCI, and mortality).
Second, operator volume was modeled dichotomously rather than continuously, with a threshold of 75 procedures per year (reflecting the BCIS guidelines recommending a minimum of 150 procedures every two years) and also 50 procedures per year (as per ECS/EAPCI and ACCF/AHA/SCAI guidelines). 
Third, the interactive effect between operator volume and centre volume was examined. The additional predictive value of an interaction term between dichotomised operator volume (at 75 procedures per year) and categorised centre volume (0-300, 301-600, 601-1200, 1201+ procedures per year) was assessed using a Wald test26.
Fourth, operator-modifiable factors (stent type, access site and adjunct pharmacotherapy) were added as covariates (these were excluded in the primary analysis due to their dependence on decisions made by operators possibly relating to operator experience). A model that did not include IABP support, cardio-pulmonary support or inotropic support was also considered (these variables were included in the primary analysis as they are strong markers of haemodynamic instability and their use may be a matter of necessity rather than choice).
Software
	All analyses were performed using R version 3.2.229. The tidy verse data manipulation and visualization suite30 was used throughout. Multiple imputation and model-pooling were implemented using the mice package31, mixed effects modeling using the lme4 package32, and restricted cubic splines using the rms package33. The analysis script is available on request from the first author.
Results
	A total of 158,492 PCI procedures were recorded to the BCIS audit in England and Wales between 2013 and 2014. Following exclusions as described in Figure 1, there were 133,970 (84.5%) procedures available for analysis. In total there were 84 centres and 540 unique consultant GMC number identifiers in this cohort. This equates to an average of 6.4 consultants per centre, 124 procedures per operator per year and 797 procedures per centre per year. The mean age of the study cohort was 65.1 years (standard deviation 12.1), and 74.3% of procedures were in male patients. Elective PCI accounted for 34.6% of procedures. There were 6,141 (4.6%) procedures from operators whose volume was under 75 procedures per year (ppy).
	Figure 2 shows the distribution of the average operator volume during the study. The median operator performed 135 ppy (interquartile range 93-188 ppy). There were 114 operators (21.1%) who had an average volume of less than 75 procedures per year, and 77 operators (14.3%) who performed less than 50 procedures per year on average. These operators contributed 4,127 (3.1%) and 944 (0.7%) procedures respectively.
Variables correlated with volume
	Table 2a reports patient and procedural factors overall and by volume, stratified by quartiles: Q1 0-128; Q2 129-178; Q3 179-239; Q4 240-714. The 30-day mortality rate was 2.6% though this differed significantly by volume, with mortality decreasing as volume increased, from 2.9% in the lowest volume stratum to 2.5% in the highest. Some factors relating to cardiovascular risk were typically more common when operator volume was higher, for instance previous MI (24.2% lowest volume to 29.6% highest volume), previous CABG (8.9% to 10.0%), previous stroke (3.8% to 4.7%), hypertension (52.3% to 59.1%), and PVD (3.9% to 5.8%). However, shock and ventilation were proportionally lower when volume was higher. Radial access was more common in high volume operators (57.2% to 71.8%), as was left main stem intervention (3.6% to 7.2%) and multi-vessel PCI (10.4% to 17.8%). Tables 2b and 2c reports these factors in elective–only and ACS-only cohorts respectively. 
Multivariable models
	The relationship between 30-day mortality and volume in 2013-2014 was explored in multivariable mixed effects logistic regression model. Figure 3 presents odds-ratios for operator volume for all, ACS-only and Primary PCI-only cohorts, with these values tabulated in Table 3. The full models are described in supplementary Tables 2a, 2b, and 2c. After adjustment for case-mix, there was no strong evidence of an independent linear association, with small effect sizes and high p-values.  Potential non-linear relationships between volume and 30-day mortality were explored graphically by plotting observed and model-adjusted mortality against volume. Figures 4, 5, and 6 demonstrate relatively stable model-adjusted mortality as volume varied. 

Sensitivity analyses
	The findings of the primary analyses were supported in all sensitivity analyses. Table 3 also lists odds-ratios for in-hospital mortality and in-hospital MACE, and for operator volume dichotomised at 75 and 50 procedures per year. In these models, associations for operator volume were relative small and not statistically significant. The Wald test examining the value of an interaction term suggested no significant interactive effects between operator volume and centre volume (all procedures, p=0.473; ACS, p=0.740; primary, p=0.629). The inclusion in the model of factors that depend on operator choice did not alter the direction or strength of association of volume with mortality (OR=1.02, 95% CI 0.96-1.08, p=0.533). Similarly, excluding variables relating to cardiac support did not alter results (OR=1.00, 95% CI 0.94-1.06, p=0.923). Further details of these sensitivity analyses are available in supplementary materials.
We do not adjust for multiple comparisons when reporting these sensitivity analyses. 

Discussion
	This nationally representative study is the first to investigate the relationship between operator volume and outcomes within the contemporary PCI era in Europe, where revascularisation following ACS is the most common indication for intervention and transradial access is the default for the majority of countries within Europe. It is the only study where volume is not calculated based on future operator activity and does not rely solely on a contrived dichotomisation or categorisation of this metric.

	Our analysis found no relationship between 30-day mortality following PCI and the number of cases performed by a PCI operator. Despite an inverse association between volume and mortality using crude, unadjusted data, we found that after adjusting for patient-level risk factors we can rule out any meaningful change in the odds of 30-day mortality as volume increases. This was observed both when operator volume was modeled continuously, and when volume was dichotomised at 50 or 75 procedures per year in line with international guidelines. Similar results were obtained in analyses of ACS only and primary PCI only procedures, and of centre-reported in-hospital mortality and in-hospital MACE. 
Procedures performed by lower volume operators were on average performed to treat patients at higher baseline risk. This is consistent with the finding that there are proportionally more ACS-indicated procedures when volume is low than when volume is high. Conversely, baseline cardiovascular risk typically increased with volume, a pattern that broadly persisted when looking at elective and ACS procedures separately.
	The existing literature investigating the relationship of operator volume on outcomes following PCI reports discrepant findings, with some studies reporting increases in adverse events with lower operator volume after risk-adjustment3–7, and others finding no such association8–16. Further, significant heterogeneity exists in the statistical methods used, particularly regarding volume threshold definitions and the settings from which the data are derived. Despite this, a large meta-analysis34 pooled aggregate data from 23 studies which included 1,109,103 patients, and found no strong evidence of short term mortality reductions against annualised dichotomised operator volume (high vs. low volume OR = 0.96, 95% CI 0.86 to 1.08 in all studies; OR = 0.90, 95% CI 0.79 to 1.01 in high and very-high quality studies only), although there was some evidence of a reduction in MACE for high-volume operators (high vs. low volume OR = 0.62, 95% CI 0.40 to 0.97).This meta-analysis was undertaken prior to a study by Badheka et al6 in 457,498 procedures identified from the National Inpatient Sample (NIS) database between 2005-2009 that showed lower in-hospital mortality in higher volume quartiles compared with the lowest quartile (1-15ppy), with the highest volume quartile (>100ppy) associated with the most significant reduction (OR = 0.65, 95% CI 0.58 to 0.73, P<0.001). However, as these studies stem from procedures performed no later than 2010, their relevance in informing contemporary best practice is diminished and should be interpreted with this in mind. In particular, this period has seen a rapid transition from trans-femoral to trans-radial access in the UK, with radial procedures rising from 16% in 2005 to over 75% in 201435. The benefits of radial access has been demonstrated in randomised controlled trials36,37, and as the strength of this benefit is positively associated with operator volume38, radial uptake may have altered the volume-outcome relationship.
	Two contemporary studies using data after 2010 can offer some insight here. An analysis of 3,747,866 procedures from July 2009 to March 2015 from the NCDR CathPCI Registry7, which captures over 90% of PCIs in the USA, found a small increase in in-hospital mortality for each 50-case decrease in annual volume (OR 1.04, 95% CI 1.03 to 1.05), and this relationship persisted in stable, UA/STEMI and STEMI PCI subgroups. Radial access rates in this study were only 15.2%, and the inclusion of data from as early as 2009 without considering temporal trends or contemporary subgroups, limits the relevance of this study to the UK experience. An analysis of 323,322 procedures in 2014 and 2015 from the Japanese PCI Registry15 reported no significant differences in in-hospital mortality or a composite of peri-procedural complications outcome between operator volume deciles. Despite drawing data from a similar era and comparable radial access rates (61.3% in Japan vs 67.5% in our study), geo-cultural disparities and average volume levels make translating these findings to Europe difficult. Our study adds a European perspective, reflecting a recent PCI era and showing that increasing volume is not associated with better mortality outcomes, and also that the majority of operators have caseloads exceeding previously defined volume thresholds.
	Median annualised volume in our study was 135 ppy (IQR 93 to 188). This is markedly higher than that found in the NIS database in theUS6 (between 33 and 58 ppy), the CathPCI Registry7 (59ppy, IQR 21 to 106) and in the J-PCI registry in Japan15 (28 ppy, IQR 10 to 56). Furthermore, 44% of operators performed <50 PCI procedures per year in the CathPCI registry, whereas in the current analysis with only 8.9% and 16.9% of operators performing less than 50 and 75 procedures per year respectively. Such differences in operator volume distribution across the two healthcare systems may contribute to the differences in the reported findings.
	The 150 minimum operator volume over two years recommended by BCIS and EAPCI17,39 was met or exceeded in 95.4% of analysed procedures, as measured using volume (i.e., exceeding 75ppy). A sensitivity analysis found no difference in 30-day mortality above or below this threshold after risk adjustment. The ACCF / AHA / SCAI guidelines stipulating a minimum of 50 procedures per year were not met in just 1.4% of cases, making a well-powered and balanced analysis of this particular recommendation challenging.
	There are fewer studies of operator volume and outcome for primary PCI. Two studies4,12 investigating this relationship directly found post-adjustment in-hospital mortality reductions for operators performing over 11 primary procedures annually (relative risk high vs. low 0.43, 95% CI 0.21-0.83) or over 10 primary procedures annually (OR 0.66, 95% CI 0.48-0.92). A small (N=331) single-centre, three-operator study was also conducted40 but with only one operator in each volume ‘group’, it is impossible to consider the effect of volume independent of other operator factors. Finally in the CathPCI study, the relationship between operator volume and in-hospital mortality was significant in patients presenting with STEMI with similar findings in the PPCI cohort (OR: 1.03; 95% CI: 1.02 to 1.04). The findings of these studies are not supported by our data, which suggest mortality following primary PCI is not associated with either total volume or primary specific volume, though there was considerable uncertainty around the central estimates. The need to achieve adequate geographical coverage to ensure timely access to primary PCI services, meet minimum centre activity standards, and accommodate a changing population means that future services are likely to continue to see a period of transition, affecting both centre and operator volumes. Volume-related outcome patterns in the primary PCI setting should therefore continue to be closely monitored.
	Centre volume was not the focus of this study but it was included as a potential confounder in the regression models. Consistent with a recent study using the BCIS registry from 2007 to 201341 we found no change in 30-day mortality as centre volume varied. However, there appeared to be a strong relationship between centre volume and in-hospital adverse events, with higher volume centres associated with higher rates of in-hospital mortality and MACE. 
Limitations
	Investigations into volume-outcome relationships are hindered by the fact that volume cannot be independently randomised. This restricts the body of statistical evidence to non-randomised volume exposures, where the influence of confounding factors must always be carefully considered and controlled for where possible.
	Our volume metric measures the number of procedures as the responsible consultant but it was necessary to exclude cases where consultant identifier was not known or where volume, mortality or other key variables were unavailable, though this study was still able to retain 84.5% of all available procedures, which compares favourably to other recent registry-based volume studies, for example with 54.5%6 and 73.8%15 in the NIS database and the J-PCI registry respectively. We note that although consultant identifier is not likely to be missing at random, missing values were present in high and low volume centres similarly, and the use of random effects mitigates the potential bias induced by these exclusions. 
	Where volume is very low or zero it is unclear whether this is because the operator was inactive (for example due to maternity leave), was working outside the UK, had not yet been appointed to consultant grade, or whether an uncommon or incorrect operator alias was used. Furthermore, only three operators had volume recorded greater than 500ppy, with just one exceeding 700ppy, and so the volume-mortality relationship in this range cannot be adequately disassociated from the relationship of mortality with individual operators. The relationship between volume and mortality in very low volume or very high volume cases should be interpreted with caution. In particular, the potential association of mortality and volume below recommended operator minimums cannot be addressed by our analysis, although we do not observe any signals towards compromised outcomes in operators performing below national / international recommendations. Centres and operators were anonymised, and additional variables at these levels, for example operator age, years since qualification, or total career PCI volume could not be accounted for. 
We considered in-hospital mortality and MACE as secondary outcomes, although this information cannot be independently validated and is therefore less robust than 30-day mortality.  We cannot rule out that other clinical end-points may be independently associated with operator volume.
Finally we were unable to consider whether total career volume may influence the relationships that we report, as operator identifiable information (the GMC number) was only available since 2012. 

Conclusion
	In our two year study in PCI procedures in England and Wales, we find no direct relationship between 30-day mortality and operator volume after adjusting for patient characteristics. This finding holds when looking at ACS and primary procedures separately. A vast majority of operators had caseloads exceeding the yearly minimum recommended by BCIS, EAPCI, and ACCF / AHA / SCAI. 
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